www.fdanews.com/articles/127316-fda-accepts-clinical-data-8217-s-nda-for-vilazodone-for-major-depressive-disorder
FDA Accepts Clinical Data’s NDA for Vilazodone for Major Depressive Disorder
May 24, 2010
Clinical Data Monday announced that the FDA has accepted for filing the Company’s New Drug Application (NDA) for vilazodone for the treatment of major depressive disorder.
MarketWatch
MarketWatch